Zdrowie i gospodarka · 16/06/2026

Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program Proposed Rule

The proposed rule would codify the Medicare Drug Price Negotiation Program and establish new policies for the program and the Medicare Prescription Drug Benefit Program, as required by the Inflation Reduction Act of 2022. It would also propose a modification to the fixed combination drug policy.